5-HT1A receptor-mediated phosphorylation of extracellular signal-regulated kinases (ERK1/2) is modulated by regulator of G protein signaling protein 19

Cellular Signalling

Volumn 26, Issue 9, 2014, Pages 1846-1852

  Wang, Qin ^a   Terauchi, Akiko ^b,c   Yee, Christopher H ^b   Umemori, Hisashi ^b,c   Traynor, John R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

FGF2; Hippocampal neurons; MAP kinase; Regulator of G protein signaling; Serotonin 1A receptor (5 HT1A); SH SY5Y cells

Indexed keywords

ADENYLATE CYCLASE; FIBROBLAST GROWTH FACTOR RECEPTOR 1; G ALPHAI2 PROTEIN; GTPASE ACCELERATING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REGULATOR OF G PROTEIN SIGNALING PROTEIN 19; RGS PROTEIN; SEROTONIN 1A RECEPTOR; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; FIBROBLAST GROWTH FACTOR 2; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; REGULATOR OF G-PROTEIN SIGNALLING 19; RGS4 PROTEIN; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DRUG EFFECTS; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOUSE; PHOSPHORYLATION; RNA INTERFERENCE;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADENYLATE CYCLASE; ANIMALS; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; GTP-BINDING PROTEIN ALPHA SUBUNIT, GI2; HUMANS; MICE; MICE, INBRED ICR; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, SEROTONIN, 5-HT1A; RGS PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84901846753     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.04.017     Document Type: Article

References (43)

1. Traynor J.R., Neubig R.R. Mol. Interv. 2005, 5:30-41.
2. Neubig R.R., Siderovski D.P. Nat. Rev. Drug Discov. 2002, 1:187-197.
3. Hollinger S., Hepler J.R. Pharmacol. Rev. 2002, 54:527-559.
4. Lan K.L., Sarvazyan N.A., Taussig R., Mackenzie R.G., DiBello P.R., Dohlman H.G., Neubig R.R. J. Biol. Chem. 1998, 273:12794-12797.
5. Lan K.L., Zhong H., Nanamori M., Neubig R.R. J. Biol. Chem. 2000, 275:33497-33503.
6. Zhong H., Neubig R.R. J. Pharmacol. Exp. Ther. 2001, 297:837-845.
7. Clark M.J., Harrison C., Zhong H., Neubig R.R., Traynor J.R. J. Biol. Chem. 2003, 278:9418-9425.
8. Fu Y., Zhong H., Nanamori M., Mortensen R.M., Huang X., Lan K., Neubig R.R. Methods Enzymol. 2004, 389:229-243.
9. Talbot J.N., Jutkiewicz E.M., Graves S.M., Clemans C.F., Nicol M.R., Mortensen R.M., Huang X., Neubig R.R., Traynor J.R. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11086-11091.
10. Stewart A., Maity B., Wunsch A.M., Meng F., Wu Q., Wemmie J.A., Fisher R.A. FASEB J. 2014, 28:1738-1744.
11. Ghavami A., Hunt R.A., Olsen M.A., Zhang J., Smith D.L., Kalgaonkar S., Rahman Z., Young K.H. Cell. Signal. 2004, 16:711-721.
12. Wang Q., Liu M., Mullah B., Siderovski D.P., Neubig R.R. J. Biol. Chem. 2002, 277:24949-24958.
13. Wang Q., Liu-Chen L.Y., Traynor J.R. J. Biol. Chem. 2009, 284:18357-18367.
14. Wang Q., Traynor J.R. Mol. Pharmacol. 2013, 83:512-520.
15. Beyer C.E., Ghavami A., Lin Q., Sung A., Rhodes K.J., Dawson L.A., Schechter L.E., Young K.H. Brain Res. 2004, 1022:214-220.
16. Gu Z., Jiang Q., Yan Z. Mol. Pharmacol. 2007, 71:1030-1039.
17. De Vries L., Lou X., Zhao G., Zheng B., Farquhar M.G. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:12340-12345.
18. Levitt E.S., Purington L.C., Traynor J.R. Mol. Pharmacol. 2011, 79:461-471.
19. Cussac D., Rauly-Lestienne I., Heusler P., Finana F., Cathala C., Bernois S., De Vries L. Cell. Signal. 2012, 24:1648-1657.
20. Borroto-Escuela D.O., Romero-Fernandez W., Mudó G., Pérez-Alea M., Ciruela F., Tarakanov A.O., Narvaez M., Di Liberto V., Agnati L.F., Belluardo N., Fuxe K. Biol. Psychiatry 2012, 71:84-91.
21. Clark M.J., Traynor J. Methods Enzymol. 2004, 389:155-169.
22. Teranchi A., Johnson-Venkatesh E.M., Toth A.B., Javed D., Sutton M.A., Umemori H. Nature 2010, 465:783-787.
23. Wang Q., Traynor J.R. J. Biol. Chem. 2011, 286:7854-7864.
24. Wiznerowicz M., Trono D. J. Virol. 2003, 77:8957-8961.
25. Stratinaki M., Varidaki A., Mitsi V., Ghose S., Magida J., Dias C., Russo S.J., Vialou V., Caldarone B.J., Tamminga C.A., Nestler E.J., Zachariou V. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:8254-8259.
26. Erratum in: Proc. Natl. Acad. Sci. U S A 110, 2013:11660.
27. Rivero G., Gabilondo A.M., García-Sevilla J.A., Callado L.F., La Harpe R., Morentin B., Meana J.J. Psychopharmacology (Berl) 2013, 226:177-188.
28. Huuhka K., Kampman O., Anttila S., Huuhka M., Rontu R., Mattila K.M., Hurme M., Lehtimäki T., Leinonen E. Neurosci. Lett. 2008, 437:25-28.
29. Storaska A.J., Neubig R.R. Methods Enzymol. 2013, 522:133-152.
30. Storaska A.J., Mei J.P., Wu M., Li M., Wade S.M., Blazer L.L., Sjögren B., Hopkins C.R., Lindsley C.W., Lin Z., Babcock J.J., McManus O.B., Neubig R.R. Cell. Signal. 2013, 25:2848-2855.
31. Raymond J.R., Olsen C.L., Gettys T.W. Biochemistry 1993, 32:11064-11073.
32. Raymond J.R., Mukhin Y.V., Gelasco A., Turner J., Collinsworth G., Gettys T.W., Grewal J.S., Garnovskaya M.N. Pharmacol. Ther. 2001, 92:179-212.
33. Shah B.H., Catt K.J. Trends Neurosci. 2004, 27:48-53.
34. Pyne N.J., Pyne S. Trends Pharmacol. Sci. 2011, 32:443-450.
35. Delcourt N., Bockaert J., Marin P. Trends Pharmacol. Sci. 2007, 28:602-607.
36. Jarosik J., Legutko B., Werner S., Unsicker K., von Bohlen Und Halbach O. Restor. Neurol. Neurosci. 2011, 29:153-165.
37. Turner C.A., Gula E.L., Taylor L.P., Watson S.J., Akil H. Brain Res. 2008, 1224:63-68.
38. Kato M., Okugawa G., Wakeno M., Takekita Y., Nonen S., Tetsuo S., Nishida K., Azuma J., Kinoshita T., Serretti A. Eur. Neuropsychopharmacol. 2009, 19:718-725.
39. Gaughran F., Payne J., Sedgwick P.M., Cotter D., Berry M. Brain Res. Bull. 2006, 70:221-227.
40. Lou X., Yano H., Lee F., Chao M.V., Farquhar M.G. Mol. Biol. Cell 2001, 12:615-627.
41. Beaulieu J.M. Int. J. Neuropsychopharmacol. 2007, 10:3-6.
42. Beaulieu J.M., Zhang X., Rodriguiz R.M., Sotnikova T.D., Cools M.J., Wetsel W.C., Gainetdinov R.R., Caron M.G. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1333-1338.
43. Li X., Zhu W., Roh M.S., Friedman A.B., Rosborough K., Jope R.S. Neuropsychopharmacology 2004, 29:1426-1431.